Suppr超能文献

癌蛋白 v-ErbA 向聚集物的募集。

Recruitment of the oncoprotein v-ErbA to aggresomes.

机构信息

Department of Biological Sciences, Hampton University, Hampton, VA 23668, United States.

出版信息

Mol Cell Endocrinol. 2011 Jan 30;332(1-2):196-212. doi: 10.1016/j.mce.2010.10.012. Epub 2010 Nov 12.

Abstract

Aggresome formation, a cellular response to misfolded protein aggregates, is linked to cancer and neurodegenerative disorders. Previously we showed that Gag-v-ErbA (v-ErbA), a retroviral variant of the thyroid hormone receptor (TRα1), accumulates in and sequesters TRα1 into cytoplasmic foci. Here, we show that foci represent v-ErbA targeting to aggresomes. v-ErbA colocalizes with aggresomal markers, proteasomes, hsp70, HDAC6, and mitochondria. Foci have hallmark characteristics of aggresomes: formation is microtubule-dependent, accelerated by proteasome inhibitors, and they disrupt intermediate filaments. Proteasome-mediated degradation is critical for clearance of v-ErbA and T(3)-dependent TRα1 clearance. Our studies highlight v-ErbA's complex mode of action: the oncoprotein is highly mobile and trafficks between the nucleus, cytoplasm, and aggresome, carrying out distinct activities within each compartment. Dynamic trafficking to aggresomes contributes to the dominant negative activity of v-ErbA and may be enhanced by the viral Gag sequence. These studies provide insight into novel modes of oncogenesis across multiple cellular compartments.

摘要

聚集物形成是细胞对错误折叠蛋白聚集的一种反应,与癌症和神经退行性疾病有关。之前我们发现,Gag-v-ErbA(v-ErbA),一种甲状腺激素受体(TRα1)的逆转录病毒变体,会在细胞质中积累并将 TRα1 隔离到细胞内的焦点中。在这里,我们表明焦点代表 v-ErbA 靶向聚集物。v-ErbA 与聚集物标记物、蛋白酶体、hsp70、HDAC6 和线粒体共定位。焦点具有聚集物的标志性特征:形成依赖微管,被蛋白酶体抑制剂加速,它们破坏中间丝。蛋白酶体介导的降解对于清除 v-ErbA 和 T(3)依赖性 TRα1 清除至关重要。我们的研究强调了 v-ErbA 的复杂作用模式:这种癌蛋白具有高度的流动性,在核、细胞质和聚集物之间穿梭,在每个隔室中执行不同的活性。动态运输到聚集物有助于 v-ErbA 的显性负活性,并且可能被病毒 Gag 序列增强。这些研究为跨多个细胞隔室的新型致癌模式提供了深入了解。

相似文献

1
Recruitment of the oncoprotein v-ErbA to aggresomes.
Mol Cell Endocrinol. 2011 Jan 30;332(1-2):196-212. doi: 10.1016/j.mce.2010.10.012. Epub 2010 Nov 12.
2
Proteasome inhibition drives HDAC6-dependent recruitment of tau to aggresomes.
J Mol Neurosci. 2011 Sep;45(1):32-41. doi: 10.1007/s12031-011-9502-x. Epub 2011 Feb 22.
3
Cancer promoted by the oncoprotein v-ErbA may be due to subcellular mislocalization of nuclear receptors.
Mol Endocrinol. 2005 May;19(5):1213-30. doi: 10.1210/me.2004-0204. Epub 2005 Jan 13.
4
Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor alpha.
J Steroid Biochem Mol Biol. 1998 Nov;67(3):181-91. doi: 10.1016/s0960-0760(98)00100-9.
5
Phosphorylation of the v-erbA protein is required for its function as an oncogene.
Genes Dev. 1990 Oct;4(10):1663-76. doi: 10.1101/gad.4.10.1663.
6
Nuclear export of the oncoprotein v-ErbA is mediated by acquisition of a viral nuclear export sequence.
J Biol Chem. 2004 Apr 9;279(15):15356-67. doi: 10.1074/jbc.M308214200. Epub 2004 Jan 16.
8
Cytoplasmic dynein/dynactin mediates the assembly of aggresomes.
Cell Motil Cytoskeleton. 2002 Sep;53(1):26-38. doi: 10.1002/cm.10057.
9
Sequences required for the transition from monomeric to homodimeric forms of thyroid hormone receptor alpha and v-erbA.
Mol Cell Endocrinol. 2003 Jan 31;199(1-2):61-72. doi: 10.1016/s0303-7207(02)00299-x.
10
Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera.
J Cell Biol. 1999 Sep 20;146(6):1239-54. doi: 10.1083/jcb.146.6.1239.

引用本文的文献

2
Getting there: Thyroid hormone receptor intracellular trafficking.
J Biol Chem. 2021 Jan-Jun;296:100677. doi: 10.1016/j.jbc.2021.100677. Epub 2021 Apr 19.
3
Mediator subunit MED1 modulates intranuclear dynamics of the thyroid hormone receptor.
J Cell Biochem. 2020 Apr;121(4):2909-2926. doi: 10.1002/jcb.29532. Epub 2019 Nov 6.
4
Acetylation modulates thyroid hormone receptor intracellular localization and intranuclear mobility.
Mol Cell Endocrinol. 2019 Sep 15;495:110509. doi: 10.1016/j.mce.2019.110509. Epub 2019 Jul 15.
5
Thyroid hormone receptor localization in target tissues.
J Endocrinol. 2018 Apr;237(1):R19-R34. doi: 10.1530/JOE-17-0708. Epub 2018 Feb 12.
7
Polyglutamine toxicity is controlled by prion composition and gene dosage in yeast.
PLoS Genet. 2012;8(4):e1002634. doi: 10.1371/journal.pgen.1002634. Epub 2012 Apr 19.

本文引用的文献

1
Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma.
Oncogene. 2010 Apr 1;29(13):1909-19. doi: 10.1038/onc.2009.476. Epub 2010 Jan 11.
3
Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire.
Oncogene. 2009 Nov 26;28(47):4162-74. doi: 10.1038/onc.2009.265. Epub 2009 Sep 14.
4
Explorative study on isoform-selective histone deacetylase inhibitors.
Chem Pharm Bull (Tokyo). 2009 Sep;57(9):897-906. doi: 10.1248/cpb.57.897.
5
Thyroid receptor: roles in cancer.
Trends Endocrinol Metab. 2009 Sep;20(7):318-24. doi: 10.1016/j.tem.2009.03.011. Epub 2009 Aug 26.
6
Rheb controls misfolded protein metabolism by inhibiting aggresome formation and autophagy.
Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):8923-8. doi: 10.1073/pnas.0903621106. Epub 2009 May 20.
8
Cytoplasmic functions of the tumour suppressor p53.
Nature. 2009 Apr 30;458(7242):1127-30. doi: 10.1038/nature07986.
9
Association of v-ErbA with Smad4 disrupts TGF-beta signaling.
Mol Biol Cell. 2009 Mar;20(5):1509-19. doi: 10.1091/mbc.e08-08-0836. Epub 2009 Jan 14.
10
The physiologic aggresome mediates cellular inactivation of iNOS.
Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1211-5. doi: 10.1073/pnas.0810968106. Epub 2009 Jan 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验